Back to Search
JONATHAN LAM, PHARMD
PHARMD
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1508583782Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
88455(CA)
Research & Publications (20)
Importance of surgical margins in the management of renal cell carcinoma.
PMID 18477995·Nat Clin Pract Urol·2008
6-review
Prognostic factors and selection for clinical studies of patients with kidney cancer.
PMID 17931881·Crit Rev Oncol Hematol·2008
6-review
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
PMID 17316970·Eur Urol·2007
4-observational
Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.
PMID 17255297·Clin Cancer Res·2007
6-review
Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
PMID 17158542·J Clin Oncol·2006
6-review
Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score.
PMID 16879693·BJU Int·2006
8-other
Long-term outcomes of the surgical management of renal cell carcinoma.
PMID 16479388·World J Urol·2006
6-review
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
PMID 16194700·Urology·2005
6-review
Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
PMID 16104896·BJU Int·2005
6-review
Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
PMID 16006866·J Urol·2005
8-other
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
PMID 15880379·Cancer·2005
8-other
Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
PMID 15879764·J Urol·2005
6-review
Prostate stem cell antigen is overexpressed in prostate cancer metastases.
PMID 15814638·Clin Cancer Res·2005
4-observational
Novel approaches in the therapy of metastatic renal cell carcinoma.
PMID 15812574·World J Urol·2005
6-review
Surveillance following radical or partial nephrectomy for renal cell carcinoma.
PMID 15610692·Curr Urol Rep·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 510 S VERMONT AVE FL 17
LOS ANGELES, CA 90020 - Phone
- (503) 220-8262
Quick Facts
- NPI
- 1508583782
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile